Genetic Switches between Cancer and Emphysema Resolution of Cigarette-Smoke Induced Inflammation

Area of Science:

• Immunology
• Genomics
• Pulmonology

Background:

• Cigarette smoke exposure triggers persistent inflammation.
• Long-term effects of smoking on lung diseases like cancer, emphysema, and COPD are complex.
• Identifying specific genes involved in post-smoking inflammatory responses is crucial.

Purpose of the Study:

• To identify outlier genes associated with distinct disease outcomes in former smokers.
• To investigate the protein-level expression of identified genes in immune cells.
• To elucidate the roles of specific immune cell populations in cancer and emphysema.

Main Methods:

• Segregation of former smokers into groups based on lung function and co-existing diseases (Cancer, Emphysema, COPD).
• Venn diagram analysis to identify outlier genes and subsets.
• Protein expression analysis on immune cells (neutrophils, macrophages).

Main Results:

• Identified 23 outlier genes across 6 subsets linked to disease outcomes.
• Cancer patients showed increased CD49d expression and neutrophil numbers.
• Emphysema patients exhibited altered macrophage adhesion (CD58) and survival markers (CD95), with MMP9 downregulation.
• ANXA2 and HIV1-rev identified as potential key genes linking cancer and emphysema inflammation.

Conclusions:

• Cancer progression involves increased, 'stickier' neutrophils in the lungs.
• Emphysema progression involves 'stickier,' longevous macrophages contributing to matrix destruction.
• Specific gene expressions (SOX13, RPP38) may promote autoimmunity in emphysema.
• ANXA2 and HIV1-rev may serve as critical mediators between cancer and emphysema inflammatory pathways.